CHRISTIANSON MARK (Business Development Director) sold 32.6% of their position (10K shares) of NEUROONE MEDICAL TECHNOLOGIES CORP on the open market
Open‑market sale worth $31.8K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/2/2026ACC: 0001709738-26-000010
Officer· Business Development Director
Since Feb 2026
-10K
Net shares
Net seller
$31.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−10K
Price / share
$3.18
Trade value
$31.77K
% of position
32.6%
6/30/2026
30.69K→20.69K
Total
Net shares
−10K
Net value
-$31.77K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2026 | S · Sale | −10K | $3.18 | $31.77K | 32.6% | 30.69K | 20.69K |
| Total | −10K | -$31.77K | ||||||
Derivative Transactions0
No derivative transactions reported